106. Cryopyrin-associated periodic syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 57 / Drugs : 38 - (DrugBank : 5) / Drug target genes : 4 - Drug target pathways : 47
Cryopyrin-associated periodic syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 106 | Cryopyrin-associated periodic syndrome | - |
| 266 | Familial mediterranean fever | 4.000 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 4.000 |
| 46 | Malignant rheumatoid arthritis | 4.000 |
| 84 | Sarcoidosis | 4.000 |
| 50 | Dermatomyositis | 4.000 |
| 107 | Juvenile idiopathic arthritis | 4.000 |
| 41 | Giant cell arteritis | 2.318 |
| 56 | Behcet disease | 2.312 |
| 15 | Inclusion body myositis | 1.182 |
| 37 | Generalised pustular psoriasis | 1.100 |
| 228 | Bronchiolitis obliterans | 1.061 |
| 164 | Oculocutaneous albinism | 1.059 |
| 58 | Hypertrophic cardiomyopathy | 1.042 |
| 222 | Primary nephrotic syndrome | 1.033 |
| 28 | Systemic amyloidosis | 1.030 |
| 19 | Lysosomal storage disease | 1.029 |
| 34 | Neurofibromatosis | 1.023 |
| 65 | Primary immunodeficiency | 1.022 |
| 299 | Cystic fibrosis | 1.021 |
| 85 | Idiopathic interstitial pneumonia | 1.020 |
| 86 | Pulmonary arterial hypertension | 1.020 |
| 51 | Scleroderma | 1.018 |
| 49 | Systemic lupus erythematosus | 1.018 |
| 97 | Ulcerative colitis | 1.014 |
| 2 | Amyotrophic lateral sclerosis | 1.012 |
| 108 | TNF receptor-associated periodic syndrome | 1.000 |
| 267 | Hyper-IgD syndrome | 1.000 |